24.04.2008
opracowanie na podstawie: Immunogenicity, reactogenicity and safety of two-dose versus three-dose (standard care) hepatitis B immunisation of healthy adolescents aged 11-15 years
a randomised controlled trial L. Heron, O. Selnikova, A. Moiseieva, P. Van Damme, M. van der Wielen, K. Levie, B. Hoet, M. Stoffel
Vaccine, 2007; 25: 2817-2822